Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should receive ...

rBIO's biosimilar insulin, R-biolin, achieves bioequivalence to Novo Nordisk Novolin® R in animal studies; company prepares for 50x scale-up and readies for in-human studies HOUSTON, Feb. 4, 2025 ...

TORONTO, ONTARIO, CANADA - Mike Conway earned his second Verizon IndyCar Series victory of the season by holding off Tony Kanaan over a three-lap sprint to the finish in the second race of the Honda ...

The top of executive of Novo Nordisk told a Senate panel Tuesday it was a "difficult choice" to discontinue the long-acting insulin Levemir but he had to do so because of market forces. The Danish ...

As a special education teacher living with Type 1 diabetes in Crawfordsville, I’ve relied on insulin to manage my condition since my diagnosis in 2011. Despite my engagement as an #insulin4all ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Abbott issued an ...

Senate Democrats are meeting with Novo Nordisk executives to address the decision to stop selling a long-acting insulin in the country; research is attempting to prove the health benefits of new ...

Novo Nordisk (NVO) is reportedly set to meet with U.S. Senate aides on Tuesday to discuss why the drugmaker is discontinuing marketing its long-acting insulin Levemir in the U.S. The Danish drugmaker ...

Twitter Summary: @US_FDA approves next-gen once-daily basal #insulin Tresiba, plus Xultophy (Victoza + Tresiba) now submitted Novo Nordisk recently announced the FDA approval of the next-generation ...

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient groups all counted the move as a win. But several ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today we have some developments about Novo Nordisk’s insulin ...

Under Congressional pressure, the price of insulin has come down in recent months, which is good news for diabetics and others who depend on it. In 2023, Novo Nordisk announced that it would reduce ...